Humacyte (HUMA) Earnings Date & Reports

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

HUMA is expected to report earnings to fall 166.46% to -18 cents per share on August 19

Q2'25

Est.

$-0.19

Q1'25

Beat

by $0.48

Q4'24

Beat

by $0.09

Q3'24

Missed

by $0.08

Q2'24

Missed

by $0.24

The last earnings report on May 13 showed earnings per share of 28 cents, beating the estimate of -20 cents. With 8.58M shares outstanding, the current market capitalization sits at 290.07M.

View a ticker or compare two or three

Compare

HUMA